Daniel S. Lee
721 Holly St.; New Milford, NJ 07646
(347)306-2328 (mobile)
dswlee@gmail.com
Legal Experience
Freelance Patent and Trademark Prosecution
Jan. 2009 – present
 Prosecuting patent and trademark applications to be submitted to United States Patent and
Trademark Office
Wilmer Cutler Pickering Hale and Dorr, LLP New York, NY
Contract Attorney
Mar. 2012 – Jun. 2012
 Reviewing of technical documents for patent litigation in the field of electrical engineering
Akin Gump Strauss Hauer & Feld, LLP New York, NY
Contract Attorney
Nov. 2011 – Feb. 2012
 Reviewing of business documents for civil antitrust litigation.
Kenyon & Kenyon - New York, NY
Mar. 2009 – Nov. 2011
Contract Attorney
 Reviewing of scientific documents for two complex pharmaceutical patent litigations.
 Drafting of memorandum summarizing interference proceedings and arguments
 Searching of documents relevant for deposition
 Preparation of privilege log for production of discovery documents.
Weil, Gotshal & Manges, LLP New York, NY
Contract Attorney
Sept. 2008 – Dec. 2008
 Reviewing of technical documents for patent litigation in the field of electrical engineering.
Stroz Friedberg, LLC and Proskauer Rose, LLP, New York, NY
Contract JD
Jun. 2008 – Sept. 2008
 Reviewing of financial documents relating to privacy/security matter.
Morgan, Lewis & Bockius, LLP
Contract JD
Feb. 2008 – Apr. 2008
 Reviewing of emails, business-related and technical documents for a litigation
 Translating Korean documents into English.
Morgan & Finnegan, LLP New York, NY
Discovery Attorney
Nov. 2006
 Reviewing of patent-related technical discovery documents for a litigation.
 Translating of technical documents in Korean language into English.
New York State Department of Environmental Conservation
Summer Intern
Jun. 2004 – Aug. 2004
 Drafting legal documents such as orders on consent, letters to respondents, memoranda of law
and legal briefs.
 Attending negotiation meetings and administrative enforcement hearings to resolve cases.
Scientific Research Experience
Merrimack Pharmaceuticals, Inc., Cambridge, MA
Senior Research Associate
May 2002 – Aug. 2003
 Development of High Throughput Screen (HTS) in a microarray format.
 Characterization of EGFR/erbB biochemical signaling pathway.
Zycos, Inc., Lexington, MA
Senior Research Associate
Aug. 2001 – Mar. 2002
 Validation of DNA vaccine therapeutics through animal studies
Graduate Studies at Brandeis University
Graduate Student
Aug. 1999 – Jul. 2001
 Study of genes and mechanisms of circadian rhythm in Drosophila melanogaster.
Dr. Albert Bendelac's Lab at Princeton University, Princeton, NJ
Research Associate
Oct. 1997 – Jul. 1999
 Characterization of a special subset of T cells called NK1 T cells in immunology
laboratory.
Dr. Bryan Crenshaw's Lab at the University of Pennsylvania, Philadelphia, PA
Research Lab Technician III
Oct. 1994 – Sept. 1997
 Generation of transgenic knockout mice and characterization of a promoter.
Dr. Daniel Kaufman's Lab at UCLA, Los Angeles, CA
Lab Assistant
Apr. 1992 – Sept. 1994
 Sequencing of murine Glutamic Acid Decarboxylase (GAD) 65 and kappa opioid
receptors.
Education
Brooklyn Law School - J.D. (2006)
Brandeis University - M.S. in Molecular Biology (2002)
 Received fellowship for one year for teaching college students enrolled in General Bio
Lab.
UCLA - B.S. in Biology (1994)
Bar Admissions
USPTO Registration No. 62,122, United States Patent and Trademark Office (2008)
Admitted to New York State Bar (2009)
Professional Skills
Fluent in Korean (read, write and speak).
Well-versed in MS Office software and electronic discovery platforms such as Concordance,
Summation, IPRO, Catalyst and many others.
Trademark Electronic Application System
Publications
1. Cloning and sequence analysis of a murine cDNA encoding glutamate decarboxylase
(GAD65). Lee DS, Tian J, Phan T, Kaufman DL. Biochim Biophys Acta. 1993 Oct
19;1216(1):157-60.
2. Characterization of the murine mu opioid receptor gene. Kaufman DL, Keith DE Jr,
Anton B, Tian J, Magendzo K, Newman D, Tran TH, Lee DS, Wen C, Xia YR, et al. J
Biol Chem. 1995 Jun 30;270(26):15877-83.
3. Changes in the subcellular localization of the Brn4 gene product precede mesenchymal
remodeling of the otic capsule. Phippard D, Heydemann A, Lechner M, Lu L, Lee D,
Kyin T, Crenshaw EB 3rd. Hear Res. 1998 Jun;120(1-2):77-85.
4. Targeted mutagenesis of the POU-domain gene Brn4/Pou3f4 causes developmental
defects in the inner ear. Phippard D, Lu L, Lee D, Saunders JC, Crenshaw EB 3rd. J
Neurosci. 1999 Jul 15;19(14):5980-9.
5. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different
cellular compartments. Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, DautryVarsat A, Bendelac A. J Exp Med. 1999 Jan 4;189(1):103-10.
6. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly
activate NK cells. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y,
Bendelac A. J Immunol. 1999 Nov 1;163(9):4647-50.
7. Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in
germ-free mice. Park SH, Benlagha K, Lee D, Balish E, Bendelac A. Eur J Immunol.
2000 Feb;30(2):620-5.